Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 39018632

Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETO.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur J Cancer
Publication date
2024 Sep
First author
Blay JY

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Blay JY
      type
      Author
    2. name
      Penel N
      type
      Author
    3. name
      Toulmonde M
      type
      Author
    4. name
      Valentin T
      type
      Author
    5. name
      Chaigneau L
      type
      Author
    6. name
      Rios M
      type
      Author
    7. name
      Saada-Bouzid E
      type
      Author
    8. name
      Firmin N
      type
      Author
    9. name
      Bertucci F
      type
      Author
    10. name
      Marec-Berard P
      type
      Author
    11. name
      Ray-Coquard I
      type
      Author
    12. name
      Lervat C
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Blay JY
      type
      Author
    2. name
      Penel N
      type
      Author
    3. name
      Toulmonde M
      type
      Author
    4. name
      Valentin T
      type
      Author
    5. name
      Chaigneau L
      type
      Author
    6. name
      Rios M
      type
      Author
    7. name
      Saada-Bouzid E
      type
      Author
    8. name
      Firmin N
      type
      Author
    9. name
      Bertucci F
      type
      Author
    10. name
      Marec-Berard P
      type
      Author
    11. name
      Ray-Coquard I
      type
      Author
    12. name
      Lervat C
      type
      Author
    bibliography ids
    1. nci-bib-b4e24508c32b5641ba8180d8
    book metadata
    content sha256
    3dafc4f6f47775f6e365fb8494b4de3c664bdec2b22696bfb06d818bc7a54fda
    document type
    citation
    dois
    1. 10.1016/j.ejca.2024.114228
    electronic publication date
    display
    2024 Jul 15
    precision
    day
    year
    2024
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:39018632
    immutable id
    pubmed:39018632@3dafc4f6f47775f6e365fb8494b4de3c664bdec2b22696bfb06d818bc7a54fda
    journal
    abbreviation
    Eur J Cancer
    issn electronic
    1879-0852
    issn print
    0959-8049
    issue
    Source null
    name
    European journal of cancer (Oxford, England : 1990)
    nlm unique id
    9005373
    pages
    114228
    volume
    208
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      39018632
      provenance
      batch id
      3e43afde6f26fc8df6da
      provider
      NCBI PubMed ESummary
      record sha256
      1f1933df1ef6105699a74fa4010af670f91f0e6d94b04d47ba181f58d5732221
      response sha256
      fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
      retrieved at
      2026-09-09T23:48:21.145285+00:00
      publication date
      display
      2024 Sep
      precision
      month
      year
      2024
      publication types
      1. Journal Article
      2. Clinical Trial, Phase II
      3. Multicenter Study
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/39018632/
      title
      Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETO.

      Preserved source evidence · Not medical advice